Precision Biosciences (DTIL) Research & Development (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Research & Development data on file, last reported at $13.1 million in Q1 2026.

• On a quarterly basis, Research & Development fell 3.52% year-over-year to $13.1 million in Q1 2026; TTM through Mar 2026 was $53.7 million, a 10.22% decrease from a year earlier, with the FY2025 full-year figure at $54.2 million, down 9.04% from the prior year.
• Research & Development for Q1 2026 stood at $13.1 million, down from $14.5 million in the prior quarter.
• Over the last five years, Research & Development for DTIL reached as high as $22.9 million in Q2 2022 and fell as low as $11.0 million in Q1 2023.
• Historically, Research & Development has averaged $14.6 million across 5 years, with a median of $13.4 million in 2025.
• Across the five-year window, Research & Development tumbled 54.67% in 2022 and surged 34.8% in 2023, its largest moves.
• Year by year, Research & Development stood at $12.7 million in 2022, then advanced by 5.57% to $13.4 million in 2023, then advanced by 18.81% to $15.9 million in 2024, then slipped by 9.07% to $14.5 million in 2025, then slipped by 9.36% to $13.1 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $13.1 million in Q1 2026, $14.5 million in Q4 2025, and $13.4 million in Q3 2025.